Search

Search Constraints

You searched for: Author/Creator Chai, K.

Search Results

2. HLX02, a China-manufactured trastuzumab biosimilar versus EU-sourced trastuzumab: Results of a global phase 3, randomized, double-blind efficacy and safety comparative study in metastatic breast cancer. (October 2020)